Wyss Institute at Harvard University

Feyisayo Eweje, an M.D./Ph.D. Candidate working with Wyss Faculty member Elliot Chaikof, is developing new technologies for delivering RNA and protein therapies directly to the body’s cells. He's co-leading a Wyss Validation Project called ENTER that aims to improve the treatment of cystic fibrosis. Learn more about Eweje in this profile from Massachusetts Institute of Technology. #Nanoparticles #DrugDelivery #CysticFibrosis https://lnkd.in/giKYkaBr

Endometriosis is a common condition that often goes undiagnosed or misdiagnosed. There is a years-long delay between the onset of symptoms and diagnosis. Through her women's health research, Shilpa P Pothapragada is bridging the gap in our understanding behind endometriosis in an attempt to close this gap. Learn more about her work: https://lnkd.in/euzmppmS #WyssWomensHealth #Endometriosis #WomensHealth

"The reason DoriVac is so appealing is that it’s already working, and that’s amazing." -Yang (Claire) Zeng DoriVac is a DNA origami vaccine developed at the Wyss by members of William Shih's lab led by Claire. They plan to first apply their technology to cancer. Learn more about her and her exciting work. #HOWyss #DNAOrigami #Vaccine #CancerResearch https://lnkd.in/eBEWi4nH

Ropirio Therapeutics, Inc., co-founded by Wyss Faculty members Christopher Chen and Sangeeta Bhatia and Wyss Medicinal Chemist Joel D. Moore, has launched to bring new solutions to patients suffering from lymphatic problems. Their company is commercializing a novel therapeutic that directly modulates the opening and closing of lymph vessels, restoring drainage even in the presence of inflammation. https://lnkd.in/e9MYWYWG

Researchers at the Wyss, led by Jennifer Lewis, developed co-SWIFT, a new printing method that creates branching vessels in heart tissue that replicate the structure of human vasculature in vitro. Learn more about this work in BostInno. https://lnkd.in/eA_MRH6T

Less than 2% of medical research funding is spent on pregnancy, childbirth, and female reproductive health. It is essential to close this gap. Through his women's health research, Justin Scott is finding ways to alleviate disease and pregnancy complications through modulating the makeup of the female genital tract microbiome. Learn more about Women's Health Innovation at the Wyss: https://lnkd.in/em3zKsdP #WyssWomensHealth #WomensHealthResearch

The Wyss' HarborSite technology overcomes key limitations of existing gene therapies by combining two proprietary genome editing technologies to enable more predictable, safe, and durable gene therapies. #GeneTherapy #Therapeutics https://lnkd.in/eWtXt23t

"Our study provides a conceptual basis for future strategies aiming to create functionally distinct T cell populations for adoptive therapies by selectively tuning mechanical input in biomaterials-based engineered cell culture systems." -David Mooney A team led by Mooney at the Wyss Institute developed a novel tunable biomaterial system that allows researchers to investigate and leverage the effects of tissue mechanics on the state of therapeutic T cells in vitro. #CellTherapy #Biomaterials #Biomechanics https://lnkd.in/eG-qYVnA

A common Alzheimer's drug could one day put people into "suspended animation" to buy them extra time to survive serious injuries and diseases. Read more in StudyFinds. https://lnkd.in/enqCGMvx #Biostasis #Therapeutics #Innovation

Breast cancer is the most common cancer worldwide, impacting nearly 15% of all women. Survivors have a lot of tricky medical decisions to make, even after they are in remission. Through her women's health research, Luba Perry, PhD is supporting breast cancer patients by developing breast reconstruction solutions that are emotionally and physically healing. Learn more about her work: https://lnkd.in/eJKK6CtF #WyssWomensHealth #CancerResearch #3DPrinting